| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6809735
[patent_doc_number] => 20030199674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/978802
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 188400
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199674.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978802 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Oct 15, 2001 | Abandoned |
Array
(
[id] => 6818220
[patent_doc_number] => 20030069178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/978423
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 188557
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069178.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978423
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978423 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Oct 15, 2001 | Abandoned |
Array
(
[id] => 6787214
[patent_doc_number] => 20030138453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Microparticles for delivery of heterologous nucleic acids'
[patent_app_type] => new
[patent_app_number] => 09/967464
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29646
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138453.pdf
[firstpage_image] =>[orig_patent_app_number] => 09967464
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/967464 | Microparticles for delivery of heterologous nucleic acids | Sep 27, 2001 | Abandoned |
Array
(
[id] => 6545217
[patent_doc_number] => 20020137714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'
[patent_app_type] => new
[patent_app_number] => 09/965116
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 8889
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137714.pdf
[firstpage_image] =>[orig_patent_app_number] => 09965116
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/965116 | Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes | Sep 25, 2001 | Issued |
| 09/960421 | Pore-forming agents for orthopedic cements | Sep 20, 2001 | Abandoned |
Array
(
[id] => 7379054
[patent_doc_number] => 20040028700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Antigenic proteins of shrimp white spot syndrome virus and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/129806
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6103
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20040028700.pdf
[firstpage_image] =>[orig_patent_app_number] => 10129806
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/129806 | Antigenic proteins of shrimp white spot syndrome virus and uses thereof | Sep 13, 2001 | Issued |
Array
(
[id] => 6787171
[patent_doc_number] => 20030138410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells'
[patent_app_type] => new
[patent_app_number] => 09/939537
[patent_app_country] => US
[patent_app_date] => 2001-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 19774
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138410.pdf
[firstpage_image] =>[orig_patent_app_number] => 09939537
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/939537 | Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells | Aug 23, 2001 | Issued |
Array
(
[id] => 270221
[patent_doc_number] => 07563455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Highly-mineralized osteogenic sponge compositions, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/923116
[patent_app_country] => US
[patent_app_date] => 2001-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3952
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563455.pdf
[firstpage_image] =>[orig_patent_app_number] => 09923116
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/923116 | Highly-mineralized osteogenic sponge compositions, and uses thereof | Aug 5, 2001 | Issued |
Array
(
[id] => 6838458
[patent_doc_number] => 20030035798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Humanized antibodies'
[patent_app_type] => new
[patent_app_number] => 09/910483
[patent_app_country] => US
[patent_app_date] => 2001-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17386
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20030035798.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910483
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910483 | Humanized antibodies | Jul 18, 2001 | Abandoned |
Array
(
[id] => 424839
[patent_doc_number] => 07270821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-18
[patent_title] => 'Hepatitis B core antigen fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 10/240917
[patent_app_country] => US
[patent_app_date] => 2001-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4769
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/270/07270821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240917 | Hepatitis B core antigen fusion proteins | Apr 8, 2001 | Issued |
Array
(
[id] => 6750938
[patent_doc_number] => 20030045459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => '67 Human secreted proteins'
[patent_app_type] => new
[patent_app_number] => 09/813153
[patent_app_country] => US
[patent_app_date] => 2001-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83132
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045459.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813153
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813153 | 67 Human secreted proteins | Mar 20, 2001 | Abandoned |
Array
(
[id] => 6898802
[patent_doc_number] => 20010046967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide'
[patent_app_type] => new
[patent_app_number] => 09/802686
[patent_app_country] => US
[patent_app_date] => 2001-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14037
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20010046967.pdf
[firstpage_image] =>[orig_patent_app_number] => 09802686
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/802686 | Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide | Mar 8, 2001 | Abandoned |
Array
(
[id] => 6822321
[patent_doc_number] => 20030220482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Novel peptide antagonist of CXCR4 derived from the N-terminus of the viral chemokine vMIP-II'
[patent_app_type] => new
[patent_app_number] => 09/773830
[patent_app_country] => US
[patent_app_date] => 2001-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8950
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220482.pdf
[firstpage_image] =>[orig_patent_app_number] => 09773830
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/773830 | Novel peptide antagonist of CXCR4 derived from the N-terminus of the viral chemokine vMIP-II | Jan 31, 2001 | Abandoned |
Array
(
[id] => 6769848
[patent_doc_number] => 20030215788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Cysteine thiol-protected peptides for use in immunoassays'
[patent_app_type] => new
[patent_app_number] => 09/733239
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10415
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215788.pdf
[firstpage_image] =>[orig_patent_app_number] => 09733239
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/733239 | Cysteine thiol-protected peptides for use in immunoassays | Dec 7, 2000 | Abandoned |
Array
(
[id] => 366277
[patent_doc_number] => 07479285
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-01-20
[patent_title] => 'Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein'
[patent_app_type] => utility
[patent_app_number] => 09/642492
[patent_app_country] => US
[patent_app_date] => 2000-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21808
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/479/07479285.pdf
[firstpage_image] =>[orig_patent_app_number] => 09642492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/642492 | Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein | Aug 17, 2000 | Issued |
| 09/555446 | Multivalent recombinant antibodies for treating hrv infections | Aug 15, 2000 | Abandoned |
| 09/630319 | METHODS FOR TREATING AND PREVENTING INFECTIOUS DISEASE | Jul 30, 2000 | Abandoned |
Array
(
[id] => 216812
[patent_doc_number] => 07611721
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-11-03
[patent_title] => 'Adjuvant combination formulations'
[patent_app_type] => utility
[patent_app_number] => 10/009473
[patent_app_country] => US
[patent_app_date] => 2000-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21547
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/611/07611721.pdf
[firstpage_image] =>[orig_patent_app_number] => 10009473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/009473 | Adjuvant combination formulations | May 11, 2000 | Issued |
| 09/565628 | Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease | May 3, 2000 | Abandoned |
Array
(
[id] => 555170
[patent_doc_number] => 07470426
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-12-30
[patent_title] => 'Treatment of neoplasms with viruses'
[patent_app_type] => utility
[patent_app_number] => 09/958809
[patent_app_country] => US
[patent_app_date] => 2000-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 27832
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/470/07470426.pdf
[firstpage_image] =>[orig_patent_app_number] => 09958809
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/958809 | Treatment of neoplasms with viruses | Apr 16, 2000 | Issued |
